Related Experiment Videos
The hemolytic-uremic syndrome: experience at a center in the Midwest
Insights
Hemolytic-uremic syndrome in children often presents with lethargy and seizures. While transfusions and dialysis are key treatments, heparin showed no clear benefit in this study of pediatric hemolytic-uremic syndrome cases.
Area of Science:
- Pediatrics
- Nephrology
- Hematology
Background:
- Hemolytic-uremic syndrome (HUS) is a serious condition affecting children.
- Understanding HUS presentation and treatment outcomes is crucial for pediatric care.
Purpose of the Study:
- To analyze the clinical features, treatment modalities, and outcomes of pediatric patients with hemolytic-uremic syndrome.
- To evaluate the efficacy of heparin as a treatment for HUS in children.
Main Methods:
- Retrospective review of 19 pediatric patients diagnosed with hemolytic-uremic syndrome between 1968 and 1976.
- Analysis of patient demographics, presenting symptoms, treatment interventions (transfusion, dialysis, heparin), and clinical outcomes.
Main Results:
- Lethargy was universal; seizures occurred in seven patients. The disease peaked in spring.
- Transfusion and dialysis were primary treatments. Heparin use in four patients did not alter disease course.
- Thirteen of 15 non-heparinized children recovered; irreversible renal failure occurred in three older children.
Conclusions:
- Early recognition of HUS symptoms like lethargy is vital.
- Standard supportive care, including transfusion and dialysis, is effective for pediatric HUS.
- Heparin did not demonstrate a significant impact on recovery or disease progression in this cohort.
Abstract:
Nineteen children with the hemolytic-uremic syndrome were treated in our hospital from 1968 to 1976. Seven were over 5 years of age. The disease occurred most often in the spring of the year. Lethargy was a prominent symptom in all patients, and seizures occurred in seven. Transfusion and dialysis were the most important treatment modalities. Heparin was used in four children and did not appear to affect the course of disease although three recovered. Thirteen of 15 children who did not receive heparin recovered. Irreversible renal failure occurred in three children, all of whom were in the older age group. Serious sequelae were rare in those who survived.